|
2024
|
Invention
|
Anti-claudin 18.2 antibody drug conjugates comprising topoisomerase i inhibitor and uses thereof.... |
|
2023
|
Invention
|
Method for preparing linker-drug conjugate. The present invention relates to a method for prepari... |
|
|
Invention
|
Sting agonists. The disclosure relates to a compound represented by formula (I), or a pharmaceuti... |
|
|
Invention
|
Heterocyclic compounds as sting agonists. The disclosure relates to a compound represented by For... |
|
|
Invention
|
Autotaxin inhibitor compound and pharmaceutical composition containing same. The present inventio... |
|
|
Invention
|
Novel auristatin precursor drug. The present invention relates to an uristatin precursor drug and... |
|
|
Invention
|
Ectonucleotide pyrophosphatase-phosphodiesterase-1 inhibitors and pharmaceutical compositions com... |
|
|
Invention
|
Imidazo[4,5-c]pyridine derivative compounds as tlr7/8 modulators. Disclosed herein are immune res... |
|
|
Invention
|
Antibody-drug conjugate comprising antibody against human trop2 and use thereof.
The present dis... |
|
|
Invention
|
Antibody-drug conjugate comprising antibody against human trop2 and use thereof. The present disc... |
|
2022
|
Invention
|
Novel antibiotic and use thereof. The present invention relates to a novel antibiotic and a use t... |
|
|
Invention
|
Antibody-drug conjugate that binds to ror1 and b7-h3, and use thereof. The present invention rela... |
|
|
Invention
|
Protein degrader conjugates and use thereof. The present invention relates to protein degrader co... |
|
|
Invention
|
Antibody-drug conjugate including antibody against human cldn18.2, and use thereof. The present i... |
|
2021
|
P/S
|
Medicinal preparations for prevention and treatment of cancer, oncological disorders, autoimmune ... |
|
|
P/S
|
Medical preparations, especially antibodies, antibody conjugates and active ingredients and antib... |
|
2020
|
Invention
|
Pyrrolobenzodiazepine derivative and ligand-linker conjugate thereof.
The present invention rela... |
|
|
Invention
|
Pyrrolobenzodiazepine derivative and ligand-linker conjugate thereof. The present invention relat... |
|
|
Invention
|
Antibody-drug conjugate comprising antibody against human ror1, and use for the same. The present... |
|
|
Invention
|
Ligand-drug conjugate including linker having tris structure.
The present invention relates to a... |
|
|
Invention
|
Ligand-drug conjugate including linker having tris structure. The present invention pertains to a... |
|
|
Invention
|
Antibody-active agent conjugates and methods of use.
The invention provides protein-active agent... |
|
|
Invention
|
Antibody-drug conjugates including antibody against human dlk1, and use thereof. The present inve... |
|
|
Invention
|
Pyrrolobenzodiazepine dimer compound with improved safety and use thereof.
The present invention... |
|
|
Invention
|
Pyrrolobenzodiazepine dimer compound with improved safety and use thereof. The present invention ... |
|
2019
|
Invention
|
Compositions and methods related to anti-cd19 antibody drug conjugates. The present disclosure re... |
|
|
Invention
|
Combination therapies for multi-drug resistant pathogens. The present invention provides pharmace... |
|
2018
|
Invention
|
Antibody-drug conjugates including antibody against egfrviii. The present invention relates to: n... |
|
|
Invention
|
Novel compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same. The ... |
|
|
Invention
|
Pyrrolobenzodiazepine dimer precursor and ligand-linker conjugate compound thereof. The present i... |
|
|
Invention
|
Compositions and methods for inhibiting β-lactamase. Substituted dihydroisoxazole derivatives use... |
|
2016
|
Invention
|
Conjugates comprising peptide groups and methods related thereto. In some aspects, the invention ... |
|
|
Invention
|
Conjugates comprising self-immolative groups and methods related thereto. In some aspects, the in... |
|
|
Invention
|
Antibody-drug conjugates comprising branched linkers and methods related thereto. The present inv... |
|
|
Invention
|
Compositions and methods for inhibiting beta-lactamase. Substituted dihydroisoxazole derivatives ... |
|
|
Invention
|
Compositions and methods for inhibiting beta-lactamase. Provided herein are substituted dihydrois... |
|
|
Invention
|
Compositions and methods related to anti-egfr antibody drug conjugates. In some aspects, the inve... |
|
|
Invention
|
Compositions and methods related to anti-cd19 antibody drug conjugates. In some aspects, the inve... |
|
|
Invention
|
Functional pillow. Disclosed is a functional pillow comprising: a base part which is formed in a ... |
|
2015
|
Invention
|
Repebody derivative-drug conjugate, preparation method and use thereof. The present invention rel... |
|
|
Invention
|
Compound containing self-immolative group. The present invention relates to a compound containing... |
|
2014
|
Invention
|
Crystalline form of 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-... |
|
|
Invention
|
Novel crystalline form of 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl... |
|
|
Invention
|
Methods of preparing antibody-active agent conjugates.
The invention provides methods for prepar... |
|
2012
|
Invention
|
Cephalosporin derivatives and pharmaceutical compositions thereof. The present invention relates ... |
|
|
Invention
|
Protein-active agent conjugates and method for preparing the same.
The invention provides protei... |
|
|
Invention
|
Protein-active agent conjugates and method for preparing the same. The invention provides protein... |
|
|
Invention
|
Imidazole-based alkaloid derivatives which have angiogenesis inhibition and antioxidant effects a... |
|
|
Invention
|
Oxazolidinone derivative and medical composition containing same. Disclosed is a novel oxazolidin... |
|
2011
|
Invention
|
Method for preparing (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(su... |
